Panagiotis Papageorgiou, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Conduction System | 8 | 2012 | 1009 | 0.580 |
Why?
|
| Sinoatrial Node | 1 | 2012 | 99 | 0.410 |
Why?
|
| Heart Block | 1 | 2012 | 390 | 0.360 |
Why?
|
| Bradycardia | 1 | 2012 | 305 | 0.360 |
Why?
|
| Tachycardia | 1 | 2012 | 598 | 0.340 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 7 | 2006 | 148 | 0.310 |
Why?
|
| Adenosine | 1 | 2012 | 817 | 0.290 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 1991 | 1493 | 0.240 |
Why?
|
| Atrial Flutter | 4 | 2002 | 253 | 0.210 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 2001 | 33 | 0.190 |
Why?
|
| Anion Transport Proteins | 1 | 2001 | 141 | 0.170 |
Why?
|
| Antiporters | 1 | 2001 | 276 | 0.170 |
Why?
|
| Heart Atria | 7 | 2004 | 1360 | 0.170 |
Why?
|
| Calcium | 5 | 1991 | 5794 | 0.150 |
Why?
|
| Tachycardia, Sinoatrial Nodal Reentry | 1 | 1997 | 8 | 0.150 |
Why?
|
| Atrial Fibrillation | 5 | 2000 | 5168 | 0.140 |
Why?
|
| Atrial Function | 1 | 1996 | 99 | 0.130 |
Why?
|
| Leptin | 2 | 2014 | 1597 | 0.130 |
Why?
|
| Atrioventricular Node | 3 | 2005 | 180 | 0.130 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2001 | 881 | 0.120 |
Why?
|
| Electrocardiography | 10 | 2006 | 6409 | 0.110 |
Why?
|
| Appetite | 1 | 2014 | 247 | 0.100 |
Why?
|
| Neurosecretory Systems | 1 | 2013 | 223 | 0.100 |
Why?
|
| Pacemaker, Artificial | 1 | 1997 | 828 | 0.100 |
Why?
|
| Atrial Function, Right | 2 | 2002 | 32 | 0.090 |
Why?
|
| Intracellular Membranes | 1 | 1991 | 388 | 0.080 |
Why?
|
| Cytoplasm | 2 | 1991 | 1502 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 3 | 2006 | 1309 | 0.080 |
Why?
|
| Myocardium | 1 | 2001 | 4788 | 0.070 |
Why?
|
| Eating | 1 | 2014 | 1541 | 0.070 |
Why?
|
| Homeostasis | 2 | 2013 | 3349 | 0.070 |
Why?
|
| Catheter Ablation | 5 | 2004 | 2776 | 0.070 |
Why?
|
| Coronary Disease | 5 | 1999 | 5924 | 0.070 |
Why?
|
| Heart Diseases | 2 | 1996 | 2819 | 0.070 |
Why?
|
| Aorta | 2 | 1991 | 2046 | 0.060 |
Why?
|
| Hypertrophy | 3 | 1991 | 562 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 1991 | 2886 | 0.060 |
Why?
|
| Aorta, Thoracic | 1 | 1991 | 1112 | 0.060 |
Why?
|
| Arrhythmia, Sinus | 1 | 2004 | 48 | 0.060 |
Why?
|
| Angiotensin II | 2 | 2001 | 847 | 0.060 |
Why?
|
| Coronary Vessels | 3 | 1999 | 3125 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2013 | 2906 | 0.050 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2001 | 59 | 0.050 |
Why?
|
| Fura-2 | 2 | 1991 | 107 | 0.050 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 2001 | 103 | 0.050 |
Why?
|
| Anions | 1 | 2001 | 137 | 0.050 |
Why?
|
| Acid-Base Equilibrium | 1 | 2001 | 181 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1991 | 2087 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 2001 | 278 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2001 | 565 | 0.040 |
Why?
|
| Hypertension | 4 | 1991 | 8615 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2001 | 1769 | 0.040 |
Why?
|
| Electric Stimulation | 2 | 1996 | 1743 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2001 | 657 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 1991 | 594 | 0.030 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1996 | 40 | 0.030 |
Why?
|
| Biological Transport | 1 | 2001 | 2085 | 0.030 |
Why?
|
| Sodium | 1 | 2001 | 1594 | 0.030 |
Why?
|
| Body Surface Potential Mapping | 1 | 1996 | 228 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2002 | 0.030 |
Why?
|
| Animals | 8 | 2012 | 169337 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1998 | 775 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6132 | 0.030 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1996 | 273 | 0.030 |
Why?
|
| Anisotropy | 1 | 1996 | 1296 | 0.030 |
Why?
|
| Blood Pressure | 1 | 1988 | 8541 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2013 | 262 | 0.020 |
Why?
|
| Aequorin | 1 | 1991 | 15 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 1527 | 0.020 |
Why?
|
| Signal Transduction | 2 | 1991 | 23631 | 0.020 |
Why?
|
| Phenylephrine | 1 | 1991 | 293 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1990 | 323 | 0.020 |
Why?
|
| Food | 1 | 2014 | 768 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1990 | 164 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 1989 | 82 | 0.020 |
Why?
|
| Ferrets | 1 | 1990 | 181 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2014 | 1004 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 1995 | 711 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 756 | 0.020 |
Why?
|
| Aortic Coarctation | 1 | 1991 | 278 | 0.020 |
Why?
|
| Aged | 13 | 2006 | 171562 | 0.020 |
Why?
|
| Ganglia, Sympathetic | 1 | 1988 | 65 | 0.020 |
Why?
|
| Constriction | 1 | 1988 | 168 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2014 | 2004 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7598 | 0.020 |
Why?
|
| Immune System | 1 | 2013 | 801 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 27454 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1990 | 617 | 0.020 |
Why?
|
| Adult | 12 | 2014 | 223640 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11120 | 0.020 |
Why?
|
| Female | 15 | 2014 | 397089 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7599 | 0.020 |
Why?
|
| Male | 15 | 2006 | 364902 | 0.020 |
Why?
|
| Middle Aged | 12 | 2006 | 223491 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12805 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1991 | 1208 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 1346 | 0.020 |
Why?
|
| Caffeine | 1 | 1990 | 702 | 0.020 |
Why?
|
| Humans | 21 | 2014 | 768393 | 0.020 |
Why?
|
| Adolescent | 6 | 2014 | 89184 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2006 | 24318 | 0.020 |
Why?
|
| Vascular Patency | 1 | 1988 | 916 | 0.020 |
Why?
|
| Rats | 2 | 1991 | 23835 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2001 | 7880 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1996 | 2056 | 0.010 |
Why?
|
| Dogs | 1 | 1988 | 3846 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2636 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2013 | 2589 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 2000 | 11516 | 0.010 |
Why?
|
| Comorbidity | 2 | 2006 | 10588 | 0.010 |
Why?
|
| Heart Septum | 1 | 2001 | 304 | 0.010 |
Why?
|
| Aged, 80 and over | 6 | 2002 | 59686 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1995 | 4543 | 0.010 |
Why?
|
| Incidence | 3 | 2004 | 21544 | 0.010 |
Why?
|
| Propafenone | 1 | 1998 | 27 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 511 | 0.010 |
Why?
|
| Quinidine | 1 | 1998 | 52 | 0.010 |
Why?
|
| Flecainide | 1 | 1998 | 41 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1988 | 4199 | 0.010 |
Why?
|
| Aging | 1 | 1996 | 8764 | 0.010 |
Why?
|
| Amiodarone | 1 | 1998 | 217 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 14737 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1988 | 3461 | 0.010 |
Why?
|
| Cognition | 1 | 2013 | 7075 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1995 | 114 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1990 | 19022 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 82017 | 0.010 |
Why?
|
| Chest Pain | 1 | 2000 | 1099 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 65379 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 685 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1990 | 9063 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2006 | 81801 | 0.010 |
Why?
|
| Echocardiography | 1 | 2002 | 5044 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 15872 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1989 | 204 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 60049 | 0.000 |
Why?
|
| Growth | 1 | 1989 | 366 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36849 | 0.000 |
Why?
|
| United States | 2 | 2006 | 73150 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 1999 | 39407 | 0.000 |
Why?
|
| Risk Factors | 2 | 2006 | 74962 | 0.000 |
Why?
|
| Time Factors | 1 | 1988 | 40272 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2660 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 13020 | 0.000 |
Why?
|
| Recurrence | 1 | 1995 | 8506 | 0.000 |
Why?
|
| Prognosis | 1 | 2000 | 30022 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 54920 | 0.000 |
Why?
|